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Abstract 
It is now generally recognised that bone marrow is the survival niche for antigen-specific 
plasma cells with long-lived immunological memory. These cells release antibodies into the 
circulation, needed to prime effector cells in the secondary immune response. These 
antibodies participate in the surveillance for antigen and afford immune defence against 
pathogens and toxins previously encountered in the primary immune response. IgE 
antibodies function together with their effector cells, mast cells, to exert “immediate 
hypersensitivity” in mucosal tissues at the front line of immune defence. The constant supply 
of IgE antibodies from bone marrow plasma cells allows the rapid “recall response” by mast 
cells upon re-exposure to antigen even after periods of antigen absence. The speed and 
sensitivity of the IgE recall response and potency of the effector cell functions are 
advantageous in the early detection and elimination of pathogens and toxins at the sites of 
attack. Local antigen provocation also stimulates de novo synthesis of IgE or its precursors 
of other isotypes that undergo IgE switching in the mucosa. Such process, however, 
introduces a delay before mast cells can be sensitized and resume activity; this is terminated 
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shortly after the antigen is eliminated. Recent results from adaptive immune receptor 
repertoire sequencing (AIRR-Seq) of immunoglobulin genes suggest that the mucosal IgE+ 
plasmablasts, which have undergone affinity maturation in the course of their evolution in 
vivo, are a source of long-lived IgE+ plasma cells in the bone marrow that are already fully 
functional. 
Introduction: Immune memory of IgE responses and their effector cells  
Immunological memory is the capacity to mount a recall response to an antigen after a 
prolonged absence of antigen, given the rapid turnover of antibodies in vivo. Such memory 
may last for the lifetime of an individual (1,2). It is embodied in selected populations of 
memory B cells and plasma cells, endowed with long-term survival compared with their 
precursors that have half-lives of only a few days or weeks. 
 
The vast majority of B cells undergo programmed cell death (apoptosis) and are regenerated 
as mature naive B cells from the bone marrow that compete for selection into the memory 
pool on the basis of their affinity for antigen. The selected cells differentiate into memory 
cells or plasma cells. The memory B cells act in the surveillance for antigen in the circulation 
and mucosal tissues. At sites of exposure to antigen, they proliferate and differentiate into 
antibody-secreting plasma cells. The majority of plasma cells are short-lived, but some 
succeed in migration to the bone marrow, which provides a survival niche. These cells 
secrete antibodies into the circulation and sensitize effector cells to antigen in all parts of the 
body. 
 
The constant supply of IgE antibodies is critical for immediate hypersensitivity in mucosal 
tissues at the frontline of immune defence. Binding of IgE antibodies to the high affinity IgE 
receptor (FcRI) on mast cells in tissues and basophils in the circulation “sensitizes” the cells 
for an anaphylactic degranulation, which is the immediate and explosive release of 
pharmacologically active pre-formed mediators from storage granules and concurrent 
synthesis of inflammatory lipid mediators from arachidonic acid. Allergic reactions are 
triggered by the binding of multivalent allergens to the IgE (discussed below), thereby 
crosslinking the FcRI receptors and initiating signal transduction leading to cell activation. 
The principle effects of these products are vasodilation and increased permeability and 
smooth muscle contraction, which are manifested in differing symptoms in rhinitis, asthma, 
atopic dermatitis, food allergy and other allergic diseases.  
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The speed and sensitivity of the mast cell reaction, triggered by allergens through IgE, 
exceed those triggered through other antibody classes. Moreover, the physiological effects 
of the products released upon antigen activation of mast cells are well-adapted to resist 
bacterial infections and neutralize toxins in the environment, preventing further harm to the 
individual. Unfortunately, this enhanced effector function is too often mis-directed in man by 
IgE recognition of normally harmless antigens, leading to the development of allergic 
disease.  
 
In this review, we discuss the natural history of IgE+ B cells, beginning with their origin in the 
primary immune response, the developmental pathway into long-lived allergen-specific 
plasma cells, and homeostasis in vivo. Focusing on the IgE response to aeroallergens in the 
respiratory track, we speculate that the respiratory track mucosa is the site where the activity 
of IgE is optimized and where bone marrow plasma cells that establish the immune memory 
of aeroallergens-induced IgE responses originate.  
 
Development of preimmune B cells in the bone marrow 
The capability of B cells to defend against a wide and ever-evolving array of pathogens is 
largely attributable to the unique diversity in their immunoglobulin (Ig) repertoire. An antibody 
molecule, either expressed as the surface B-cell receptor (BCR) or in the secreted form of a 
soluble antibody, is composed of two identical kappa () or lambda () Ig light chains (IgL) 
plus two identical Ig heavy chains (IgH; five major isotypes in humans), each containing a N-
terminal variable (V, V or VH) region and a C-terminal constant (C, C or CH) region. 
Combinatorial association between the variable regions (VH:V or VH:V) forms the antigen-
binding site of the antibody, and its effector function is determined by the expression of a 
specific CH region that corresponds to the antibody isotype (or class).  
 
During early ontogeny (Fig 1), B cells achieve combinatorial diversity through V(D)J 
recombination, which requires recombination activating gene (RAG) proteins to assemble a 
complete V, V or VH exon from component germline variable (V), joining (J), and diversity 
(D; only in VH) gene segments. This is accompanied by imprecise insertion/deletion of N/P- 
nucleotides at the junctions between the recombined gene segments, thus creating more 
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genetic and protein structural variability of the variable region. These highly variable 
junctions, commonly termed complementarity-determining regions (CDRs), correspond to six 
hypervariable loops in the three-dimensional structure of an antibody that specifically interact 
with antigens. The third CDR of VH (CDR-H3) has the greatest diversity of the six CDRs in 
amino acid residues, rendering it remarkably unique to each progenitor B cell that is 
subsequently passed on to all of its clonally expanded progeny. Indeed, CDR-H3 is routinely 
used to determine clonal lineages of B cells in studies of the antibody repertoire.  
 
The combinatorial and junctional mechanisms occur in the absence of foreign antigens in 
the bone marrow and can, in theory, produce >108 possible different antigen-binding sites 
exceeding the actual total number of B cells in a human. The recombined VH exon in a 
developing B cell is then assembled with the most 5’ constant mu (C) gene (closely linked 
to C), allowing surface BCR expression of the IgM isotype (and IgD; not discussed herein). 
Naïve (CD27–IgM+IgD+) B cells are identified as new (bone marrow) emigrant B cells that 
have completed cell maturation and succeeded the peripheral checkpoint against 
autoreactivity. Outside the bone marrow, mature naïve B cells undergo phenotypic 
differentiation and further diversify their Ig repertoire in response to antigen challenge.  
 
Antigen-driven Ig diversification and affinity maturation 
Following antigen activation, activation-induced cytidine deaminase (AID) initially in naïve B 
cells mediates class switch recombination (CSR), which displaces the IgM constant region 
(C) for the expression of a secondary isotype (IgG, IgA, or IgE) and sub-isotypes (IgG1,2,3,4 
or IgA1,2), ultimately diversifying the antibody effector functions without altering antigenic 
specificity. The germline CH genes (C3, C1, C2, C4, C, or C2) that encode non-IgM 
isotypes (IgG3, IgA1, IgG1 IgG2, IgG4, IgE, or IgA2) lie downstream to C in a tandem array 
on human chromosome 14. Proceeding each CH gene, a specific stretch of repetitive DNA, 
termed switch (S; e.g. S, S3, S etc.) region, guides AID activity to initiate CSR. Isotype 
switching from IgM requires AID to deaminate cytidines to uridines within the (donor) S and 
a downstream (acceptor) S region DNA; this leads to DNA cleavage at the deaminated 
residues, followed by DNA recombination between donor and acceptor S regions. Excision 
of switch circles by looping-out deletion of any intervening DNA subsequently enables the 
expression of a secondary CH gene with the rearranged VDJ genes. Further CSR can occur 
in a B cell between the newly expressed CH and any remaining (farther downstream) 
germline CH genes, upon interaction of its BCR with a specific antigen. 
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Isotype switching is often accompanied by somatic hypermutation (SHM), a diversification 
process that contributes to a large spectrum of antibody affinity. SHM is initiated by AID in 
stimulated B cells, which introduces point mutations into the recombined V(D)J genes, 
typically targeting certain hotspots (e.g. RGYW motifs) within CDRs ultimately to modify (and 
improve) the structure of the antigen binding site. This, together with CSR, generally occurs 
in the germinal centres (GC) of B-cell follicles in constitutive lymphoid tissues. Following 
antigen activation, B cells undergo cell division and clonal expansion, leading to the 
formation of two GC microanatomical compartments, the dark and light zones. Proliferating 
B cells In the dark zone diversify through CSR and SHM. Subsequently, antigen selection is 
achieved in the light zone where clonal members compete for antigen presentation to 
follicular T helper cells in the presence of follicular dendritic cells (DC), a crucial step in 
affinity maturation of functional antibodies (3). If GC B cells survive antigen selection, they 
either re-cycle through the dark zone for further Ig modifications, or after phenotypic 
differentiation exit the GC as memory (IgD–CD27+) B cells or plasmablasts 
(CD19+CD27hiCD38hiCD138-) that may eventually join the long-lived (CD19–
CD27hiCD38hiCD138+) plasma cell population in the bone marrow. 
 
IgE, together with IgG and IgA, is one of the three “switched” isotypes evolved through CSR. 
IgE switching can occur directly from IgM (IgMIgE) or sequentially through one or more of 
the prior-switched intermediates (IgMIgG3IgG1IgA1IgG2IgG4IgE); IgE may switch 
to IgA2 by replacing C with the last germline C2 gene segment. Since affinity maturation 
can occur in the precursors of IgE+ B cells, the pathway of IgE switching has significant 
implications for IgE affinity to antigen: direct switching to IgE from an IgM+ precursor may 
result in low IgE affinity and apoptosis of GC B cells during selection (4), whereas 
sequentially-switched IgE can “inherit” a higher affinity from the hypermutations previously 
selected in IgG+/IgA+ precursors (5).  
 
Antigens and IgE antibodies for effector function 
The minimal requirement for mast cell activation is the crosslinking of its high-affinity IgE 
receptors, FcRI molecules, on the surface of the mast cell. This is normally effected by 
antigen or allergen binding to IgE–FcRI complexes on the mast cell and makes stringent 
demands on the antigen. It has been shown that the spacing between the two adjacent 
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complexes is critical (6) and there are undoubtedly topological complexities that are not yet 
fully understood. Unlike antibodies of other isotypes, IgE can assume an acutely bent 
conformation (7), which may lead to steric interference from the cell in the binding of certain 
epitopes. Antibodies of the five different isotypes have different “reach”, depending on the 
length and flexibility of their hinge regions. Thus, the specificity for antigen binding may vary 
between antibodies of different isotypes. 
 
Nevertheless, certain general rules apply to the crosslinking of FcRI on mast cells and 
basophils by allergens. Crosslinking can occur under the following circumstances:  
(1) Antigens, such as certain pathogens, polysaccharide chains or DNA molecules may 
contain several identical epitopes, which bind to IgE molecules of the same specificity (Fig. 
2A) 
(2) Antigens with a single epitope may form non-covalently linked oligomers (homodimers, 
trimers, etc.), each of which binds to IgEs of the same specificity (Fig. 2B).  
(3) Antigens may contain at least two different epitopes, disposed in a manner that allows 
simultaneous attachment to these IgEs of the corresponding specificities (on the same mast 
cell). Such allergens may be particularly efficient in crosslinking IgEs on mast cells (Fig. 2C). 
The multiple epitopes on the peanut Ara h2 allergen, described below (8), may allow it to 
initiate an allergic reaction.  
 
(4) There may also be more than one allergen in allergenic materials, such as grass pollen 
in combination with house dust mite (HDM) faecal pellets. Each may satisfy one of the 
above criteria (Fig. 2A–C) and form separate complexes on the same mast cell, contributing 
to the additive effect on the strength of mast cell activation (Fig. 2D).  
 
In addition, there are requirements of the antigen-specific IgE antibodies, as 
comprehensively investigated by Lund and co-workers (9). They comprise total IgE 
concentrations, concentrations of allergen-specific IgE relative to non-allergen-specific IgE, 
similarity in the concentrations of individual allergen-specific IgE clones, IgE affinity for 
allergen and clonal diversity. The interplay of these factors affects the severity of allergic 
responses.  
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Regulation of IgE and homeostasis 
IgE is the least abundant of the five antibody isotypes (IgM, IgD, IgG, IgA and IgE); the 
serum concentration of IgG is about 10,000 times higher than that of IgE in non-allergic 
subjects (20–30 vs. 0.001 mg/ml). Although it is highly variable, the concentration of IgE is 
only on average three times higher in allergic individuals. In light of its inflammatory and 
potentially adverse effects, i.e. uncontrolled mast cell activation or basophil activation that 
can lead to life-threatening systemic anaphylaxis or acute severe asthma exacerbations, a 
wide variety of immunoregulatory mechanisms are necessary to suppress IgE expression 
(10,11).  
 
It is evident from the low frequency of IgE switching (12) and poor survival of nascent IgE+ B 
cells (5,13,14) that the expression of is generally suppressed to restrict the immune 
repertoire of IgE+ B cells in the system. This occurs at many stages in the lifetime of IgE+ B 
cells and can be observed following antigen stimulation (15), phenotype and clonal lineage 
determination (5,16), and chemokine-directed cell migration toward specific anatomical 
compartments (17). Unlike other antibody classes, membrane IgE (as BCRs) remains active 
for cell signalling even in the absence of allergen (14,18), but its expression can be 
regulated by soluble CD23 (19). It is expected that this will lead to the discovery of new 
targets for clinical intervention in the development and progression of allergic disease.  
 
Secreted IgE has a short half-life in mucosal tissues of approximately two weeks in situ, in 
spite of the fact that IgE dissociates from its high-affinity receptor more slowly than any other 
isotypes from their corresponding receptors (20). Yet, immediate hypersensitivity can be 
maintained for decades after initial allergen exposure due to the IgE+ memory plasma cells 
that reside in the bone marrow: IgE released into the periphery from bone marrow may be 
actively captured by mast cells in mucosal tissues (21) and/or transported into the mucosa 
by other effector cells expressing low affinity IgE receptors, FcRII (CD23). Under 
equilibrium conditions in vivo, mast cells in tissues have been shown to remain permanently 
sensitized to allergen. Upon renewed allergen stimulation, IgE is synthesized de novo by 
memory B cells that undergo IgE switching and differentiation into IgE+ plasma cells 
(13,14,22). The delay, however, would not support IgE-mediated immediate hypersensitivity, 
highlighting its unique dependence on long-lived IgE+ plasma cells in the bone marrow.  
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The origin of IgE immune memory 
Evidence that bone marrow is the repository of allergic memory was at hand in 1919, well 
before the discovery in 1961 of IgE. A clinical case study described a non-allergic patient 
who, after a bone marrow transplant from a horse-allergic donor, suffered an asthma attack 
while riding a horse in Central Park, New York (23). This report, and other following studies 
of transplant-acquired allergies (24), did not identify the cell populations that transferred IgE 
immune memory. Such deficiency was addressed much later using mouse models for 
adoptive transfer of B cells (4,13).  
 
As demonstrated by Talay et al., IgE+ memory (B220+IgD–GL7–CD38hi) B cells adoptively 
transferred from immunised (human M1/GFP) mice induced a serum IgE response to the 
recall antigen in naïve RAG–/– recipients (13). Using a different transgenic mouse (CεGFP- 
TBmc or BALB/c) system, Lafaille and colleagues later reported that IgE+ cells (plasma cells 
and B220+CD138– GC B cells) generated during the primary immunisation were associated 
with direct IgE switching and lower SHM rates, expected to have low IgE affinity and offer 
only transient protection (4); the immune memory of IgE responses was restricted to the 
plasma cell lineage in this mouse model, depending on the transferred IgG+ GC B cells to 
effect sequential IgE switching and, unlike their IgE+ counterparts, unable to effectively 
engage in GC reactions, to accomplish phenotypic differentiation into long-lived IgE+ plasma 
cells following the secondary immunisation in the recipient mice. The same characteristics 
may hold for the human system: antibody secretion by IgE+ plasma cells transiently present 
in the peripheral circulation alone, assayed by the in vitro incubation of peripheral blood 
mononuclear cells, was judged to be insufficient to maintain the memory of IgE responses 
(25,26). Although IgE+ memory (IgD–CD27+/-) B cells have been reported in man, their 
functions and cell fate remain unclear (27). In addition to the bone marrow, we and others 
have regarded the mucosal tissues of target organs as a peripheral source of IgE immune 
memory in asthma and allergy.  
 
Local IgE repertoire in the respiratory tract mucosa 
Early clinical studies further demonstrated that the IgE-secreting plasma cells are present in 
the nasal mucosa in patients with AR (28-30). It was shown that a sub-group of patients 
allergic to grass pollen, who had negative skin prick tests and undetectable levels of 
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allergen-specific lgE antibody in sera, had high titres of the antibodies against the allergens 
to which they reacted in their nasal secretions; this was the first evidence for local IgE 
antibody production and activity in the respiratory tract mucosa (31). 
 
Later work supported this conclusion by immunohistochemistry staining of nasal mucosal 
tissues, showing an increase in the IgE+ plasma cells in seasonal AR patients compared 
with healthy controls (30). De novo synthesis and secretion of IgE protein in the mucosa was 
confirmed by incubating nasal biopsies ex vivo with radioactive amino acids and showing 
increased amounts of radioactive IgE in the medium as a function of time (32). The 
proportion of total IgE that was grass pollen- or HDM-specific IgE ranged up to 50% in this 
ex vivo system, an invariably higher proportion than found in the circulation of the same 
individual, where it was sometimes undetectable. We calculated that a hundred times more 
IgE was produced than required to saturate all the IgE receptors on mast cells in the tissue 
(10); thus, the excess IgE must spill out into the circulation and the nasal secretions.  
 
Switch circles are the deleted by-products during CSR, containing the looped-out germline 
CH genes and a switch junction recombined from the donor (3’ the cleave site) and acceptor 
(5’ the cleave site) S regions. In IgE+ B cells directly switched from IgM, the donor S region 
is partially retained in switch circles and spliced to the acceptor S region to form one S-S 
junction in switch circles; similarly, the S donor can be joined to an S acceptor as one S-
S junction if IgM switches to IgG. For sequential switching to IgE from the IgG that has 
descended from IgM, switch circles contain either S-S or S-S-S junctions; this depends 
on whether AID cleaves the S or S portion of the S-S donor (a hybrid S region resulted 
from IgM to IgG switching) before being recombined with the acceptor S region. In any 
case, the presence of S DNA (or similarly S1) in switch circles provides strong evidence of 
sequential switching.  
 
We and others have used switch junctions (S-S or S-S in switch circles) as molecular 
markers for local isotype switching to IgE in the bronchial mucosa of asthma (33) and in the 
nasal mucosa of AR (34,35). S-S4 junction DNA was detected at the highest frequency in 
switch circles after the ex vivo allergen incubation of the nasal biopsies from AR patients 
sampled out of pollen season (35). This highlighted affinity maturation of the IgG4 precursors 
with prior allergen exposure and sequential switching to IgE in local mucosal tissues as the 
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important process of IgE development in seasonal AR. As IgG4 is the most downstream of 
IgG sub-isotype in the human CH gene locus, it has maximum opportunity to have 
undergone affinity maturation following antigen activation and compete with IgE for antigen, 
relevant to observations in immunotherapy discussed below. As expected from active GC 
reactions (SHM and CSR) and the presence of AID transcripts, clusters of B cells (potentially 
precursors of ectopic GCs) were observed in the mucosal tissues (35). 
 
Migration of mucosal plasma cells to the bone marrow 
To test whether the nasal mucosa is the direct source of IgE+ plasma cells in the bone 
marrow, Luger et al. immunized mice with ovalbumin and then challenged them with oral 
inhalation of an ovalbumin-containing aerosol (15). At varying times thereafter, the mice 
were treated with cyclophosphamide to kill dividing B cells, while sparing the plasma cells in 
bone marrow that have ceased dividing. While mice were exposed to ovalbumin, B cells 
proliferated into plasma cells of IgG1, IgA and IgE isotypes in the lung and the animals 
developed airway inflammation. Plasma cells from the mucosa joined the pool of ovalbumin-
specific plasma cells in the bone marrow and became resistant to cyclophosphamide. 
Termination of ovalbumin inhalation depleted ovalbumin-specific plasma cells from the 
lungs, while preserving them in the bone marrow. This incisive experiment proves that the 
respiratory mucosa is a major source of aeroallergen-directed IgE responses in the bone 
marrow of mice and confirmed that the bone marrow is the repository for IgE immune 
memory.   
 
The new step forward 
Mechanisms involved in the development of B cells can be investigated by tracing the 
molecular footprints of GC reactions in the corresponding Ig sequences. Our early Ig gene 
profiling study was the first to reveal in situ intraclonal SHM in mucosal B cells in AR by 
Sanger sequencing of 120 Ig gene sequences (36).These clones were likely to represent 
only a miniscule fraction of the entire mucosal B-cell repertoire. We and others have since 
characterised local B cells more comprehensively, using massively-parallel next-generation 
sequencing (NGS) of the adaptive immune receptor repertoire (AIRR).  
 
Adaptive immune receptor repertoire sequencing (AIRR-Seq) of B cells 
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The advent of AIRR-Seq technologies has revolutionized our capacity to study the clonal 
evolution of B cells in adaptive immunity (37-40). AIRR-Seq affords an analytic power of the 
IgE repertoire several orders of magnitude greater than Sanger sequencing, thus revealing 
previously unattainable knowledge concerning this rare and important antibody class (Table 
1). This is exemplified here by three pioneering studies of IgE repertoires in allergic disease 
(8,41,42).  
 
Influence of seasonal exposure to grass pollen on local and peripheral blood IgE repertoires 
in patients with AR (41)  
In 2014, we reported the first AIRR-Seq profiling of the mucosal IgE+ B cells in the context of 
seasonal AR (41). Large-scale analysis of VDJ-CH genes in this study revealed intraclonal 
diversification of B cells through SHM and CSR, as well mutational differences in VH 
associated with isotypes (IgA, IgG, IgM, and IgE), compartments (blood and nasal mucosa), 
and atopic status (healthy, AR outside season and AR in season).  
 
For IgE+ clones, the highest VH mutational level and strongest evidence of antigen-driven 
selection, were observed in AR subjects, particularly in nasal biopsies sampled during the 
pollen season. The study did not address the associated cell phenotypes, as in our 
unpublished work, or allergen specificity, elucidated for the first time in the two other studies 
featured below. But it demonstrated seasonal effects of natural allergen exposure on SHM 
activities and enrichment of high-affinity IgE locally in the nasal mucosa in AR. This was also 
reflected in the increased diversity of the mucosal IgE repertoire in AR during the pollen 
season, which might generate new paratopes, thereby increasing the severity of, as seen in 
the peanut allergy study (8). It must be noted that tissue-specific homing of pollen-stimulated 
B cells to the nasal mucosal tissues is an alternative explanation for these observations.  
 
In addition to IgE compartmental clonality, we discovered that the clonal relationship 
between IgE and IgG/IgA variants was restricted to the AR subjects. This, along with similar 
VH mutational levels between the three isotype-switched repertoires, suggested that 
sequential IgE switching from isotype-switched precursors plays an important process in the 
pathogenesis of AR.   
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Single cell B-cell deconvolution of peanut-specific antibody responses in allergic patients 
(42) 
By Integrating NGS with the monoclonal antibody (mAb) technology (42), Boyd and 
colleagues provided the first AIRR-Seq study on the evolution of peanut-specific IgE+ cells 
during oral allergen immunotherapy (OIT). Specific B cells for two major peanut allergens, 
Ara h1 or Ara h2, were identified in the blood by flow cytometry and subsequently expressed 
as IgG1 mAbs, capable of recognising a diverse population of conformational and/or linear 
epitopes. The Ara h2-specific mAbs, for example, recognized multiple linear epitopes in a 
24-amino acid peptide array; two of the corresponding IgEs against these epitopes may 
suffice to initiate an allergic response (Fig. 2C).  
 
Peanut-specific mAbs were clonally aligned with hypermutated IgG(2/4), IgA or IgE variants in 
the AIRR-Seq repertoire, as the indication of elevated SHM activities during OIT. These 
clones lacked intraclonal relatedness between IgM and IgE isotypes, in line with the 
hypothesis that the reactivity of IgE+ B cells to peanut allergens depended on sequential IgE 
switching and affinity maturation of isotype-switched precursors. Furthermore, the detection 
of peanut-specific IgG4 clones that were hypermutated was consistent with the putative IgE-
blocking activity of IgG4, potentially with enhanced efficacy, during OIT (43).  
 
Overall, the report by Hoh et al. indicated OIT-induced changes in the cellular and cytokine 
responses (e.g. involving helper T cells) that might redirect the pathway of isotype switching 
from peanut-specific IgE+ to IgG4
+ B cells (44). Whether this occurred within the target organ 
of peanut allergy, i.e. gut mucosa, remains to be. Interrogated. 
 
Persistence and evolution of allergen-specific IgE repertoires in specific allergen 
immunotherapy (8) 
Levin et al. carried out a longitudinal AIRR-Seq profiling of allergen-specific B cells in 
subjects undergoing specific-allergen immunotherapy (SIT) (8). In this study, specific 
allergens were administrated via the subcutaneously (differing from oral intakes in OIT), and 
IgE+ clones corresponding to seven allergen specificities were identified using phage display 
of single-chain variable fragments (scFv) (45). Blood and nasal mucosal B-cell repertoires 
were determined by AIRR-Seq, revealing similar repertoire characteristics i similar to those 
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in our report, e.g. enrichment of VH mutations in mucosal B cells in allergic subjects, 
although this was not attributable to SIT.  
 
Identification of allergen-specific IgE+ (scFv) clones that could be mapped to the AIRR-Seq 
data in the course of SIT (up to 1 year) represented the key strength of this study. The 
authors demonstrated longitudinal persistence of allergen-specific IgE+ clones that displayed 
molecular features of GC reactions, i.e. expansion, SHM and CSR, among related members. 
In line with the two aforementioned AIRR-Seq studies, IgE+ B cells (allergen specific in this 
case) were strictly related to hypermutated IgA/IgG; this could be detected in nasal biopsies, 
strengthening the concept of in situ SHM and CSR. Further analysis of multiple biopsies 
(proximal and distal sampled from same individuals) may further address how/whether the 
ontogeny of allergen-specific IgE+ B cells could be impacted by cell dissemination of within 
mucosal tissues. 
 
In summary, the observation of allergen-specific B cells with clonal members in different 
compartments is consistent with GC reactions and mobilization of resident allergen-specific 
memory B cells. The results of this work reinforce several themes developed in this review 
and underwrite our conclusions below. 
 
Conclusions 
On the basis of the evidence above, we may draw the following conclusions (Fig. 3): 
 The immune memory of IgE responses is embodied in the repertoire of plasma cells 
contained in the bone marrow. 
 IgE antibodies are adapted to equip mast cells for immediate hypersensitivity to 
antigens/allergens in mucosal tissues.  
 This mainly depends on both SHM and CSR to IgE in memory B cells prior to 
differentiation into IgE+ plasma cells. 
 Immediate hypersensitivity to aeroallergens occurs in the respiratory mucosa in 
sensitized individuals. 
 The respiratory mucosa is the source of IgE immune memory for aeroallergens in bone 
marrow in mouse.  
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 The development of IgE+ plasma cells in situ (respiratory tract mucosa) in man is 
promoted by high levels of SHM. 
 
The entire developmental process of IgE+ plasma cells, i.e. the principle of IgE immune 
memory, may take place in the mucosa itself or adjacent lymphoid tissue. Certain stages 
may involve the formation of ectopic lymphoid tissue within the mucosa or the activity of 
constitutive lymphoid tissues adjacent to the mucosa (adenoids, tonsils), followed by 
migration of memory B cells to the mucosa. Which event happens precisely where, when 
and how still remains unclear (46). 
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Abbreviations 
AID: activation-induced cytidine deaminase 
AR: allergic rhinitis 
AIRR-Seq: adaptive immune receptor repertoire sequencing 
APC: antigen-presenting cell 
BCR: B-cell receptor 
CDR: complementarity-determining region 
CDR-H3: the third complementarity-determining region of the heavy chain 
CH: constant region of immunoglobulin heavy chain (C, C, C, and C for IgA, IgE, IgG 
and IgM) 
CSR: class switch recombination 
IgH and IgL: immunoglobulin heavy and light chain 
GC: germinal centre 
DC: dendritic cell 
HDM: house dust mite 
FcRI: high-affinity IgE receptor  
FcRII: low-affinity IgE receptor (CD23) 
mAb: monoclonal antibody 
NGS: next-generation sequencing  
OIT: oral allergen immunotherapy  
RAG: recombination activating gene 
SIT: specific allergen immunotherapy 
SHM: somatic hypermutation 
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S, S, S, and S: isotype switch region for IgA, IgE, IgG and IgM 
VH and VL: variable regions of immunoglobulin heavy and light chains 
V, D, J: variable, diversity, and joining segments of immunoglobulin genes 
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Table 1 
Allergy (Ref)
1
 Cohort Size Sequencer 
IgE (total) 
reads 
Specimen
2
 Specificity Key findings 
seasonal AR (41) 
10 adults: HC=3,  
AR (in/out season)=3/4 
NGS 
(Roche 454) 
8,135 (97,610) PB, NB – in situ CSR & SHM  
peanut allergy (42) 27 OIT subjects 
(4-43 years) 
NGS 
(Illumina MiSeq) 
>100,000 
per subject 
PB mAb expression 
(5 IgE clones) 
IgE–IgG/A clonality  
aeroallergy (8) 16 adults:1-year SIT 
(with/without)=8/8 
 
NGS 
(Roche 454) 
90,241(594,364) PB, NB scFv phage display  
(52 IgE clones) 
in situ CSR & SHM  
nut allergy,  
aeroallergy (47) 
31 adults:  
allergic=9, HC=24 
NGS 
(Illumina MiSeq) 
175,585 
(15,843,270) 
PB – IgE more related to  
memory cells peanut allergy,  
bee allergy (48) 
10 subjects: 
peanut/bee=6/4 
NGS 
(Roche 454) 
31,248 (53,688) PB – Antigen selection of IgE 
seasonal AR (49) 6 adults NGS 
(Illumina MiSeq) 
7,499,998 
(31,461,115) 
PB, BM – Diverse BM IgE 
repertoire 
aeroallergy (50) 6 adults Sanger 296 PB – Restricted IgE repertoire 
AA (51) 1 adult Sanger 10 (41) PB – IgE VH5 usage bias 
AA, AD (52) 3 children Sanger 50 PB – Restricted IgE repertoire 
seasonal AR (53) 3 adults Sanger 51 PB, NB – Oligoclonal IgE 
aeroallergy (54) 1 adult Sanger 51 PB phage display Polyspecific IgE 
AA, AD (55) 13 children Sanger 1366 PB – Superantigen activation 
AA, AD (56) 14 adults Sanger 177 [VH3] PB – IgE clonal expansion 
seasonal AR (57) 17 adults: AR=13, HC=4 Sanger 51 PB, NB – Superantigen activation  
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AA (58) 1 adult Sanger 30 BB – in situ CSR & SHM 
rhinosinusitis (59) 11 adults Sanger 195 Sinus – in situ SHM 
1AA: allergic asthma, AD: atopic dermatitis.  2PB: peripheral blood, NB: nasal biopsy, BM: bone marrow, BB: bronchial biopsy
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Figures legends 
Figure. 1. Development of the IgE+ B-cell repertoire. Top-left: The primary repertoire of 
early B cells in the bone marrow acquires combinatorial and junctional diversity (shown in 
the box) through V(D)J recombination (only IgH illustrated), random paring of IgH with IgL (λ 
or κ) chains and N/P nucleotide editing at the CDR-H3 junctions (corresponding to the purple 
circle). Bottom-left: Following activation by allergen in the periphery, naive B cells undergo 
clonal expansion and further diversification via SHM in the GC dark zone. GC B cells can 
undergo CSR to IgE in two pathways: (1:green arrow) direct switching from IgM+ precursors 
or (2: blue arrow) sequential switching via IgG+ or IgA+ intermediates; the second pathway 
may occur outside lymphoid tissues, such as the ectopic GC in mucosal tissues. Following 
antigen selection in the presence of follicular T helper cells and DCs in the GC light zone, 
the selected B cells either cycle in the GC for further affinity maturation (the red dotted path) 
or differentiate into memory B cells and antibody secreting cells (plasmablastsplasma 
cells); unselected B cells undergo apoptosis. Bottom-right: IgE antibodies secreted from 
plasma cells can sensitise mast cells or antigen-presenting cells (APCs), i.e. dendritic cells 
(DCs) via FcI and B cells via FcII or CD23 (not shown). Crosslinking of IgE via FcεRI on 
mast cells induces degranulation of mast cells and release of histamine, proteases and 
metabolites that collectively effect the symptoms of allergy. Four antibody isotypes are 
coloured red for IgM, blue for IgA, purple for IgG and green for IgE. Selection processes are 
indicated by squares labelled with “S”: 1 red square for affinity-based selection in the GC 
and 3 grey squares for selection against non-autoreactive functional BCRs of the preimmune 
repertoire. 
 
Figure. 2. Models of IgE crosslinking on mast cells. Two IgE molecules on FcεRI 
receptors attached to a mast cell can be cross-linked by (A) a single antigen with multiple 
identical epitopes (i.e. “1” & “1” labelled on the antigen-binding sites), (B) an oligomeric 
antigen (e.g. a homodimer) with identical epitopes on the subunits, (C) a single antigen with 
two different epitopes and (D) two different antigens with different epitopes (e.g. combining 
mechanisms C and D). Four IgE specificities are indicated by numbers (1–4) on the antigen-
binding sites. 
 
Figure. 3. Compartmental regulation and IgE function in allergic asthma. (A) Allergen is 
inhaled into the lung and travels through the epithelial cell lining of the respiratory tract into 
the mucosa, where it is captured by DCs. (B) The DCs and cognate T helper cells induce 
GC reactions (SHM and isotype switching to IgE) in allergen-specific B cells, causing their 
rapid differentiation into IgE-secreting cells (Fig.1). (C) IgE+ plasmablasts migrate from local 
respiratory mucosal tissues through circulation to the bone marrow where they receive 
survival signals as long-lived plasma cells. (D) Long-lived IgE+ plasma cells remain in the 
bone marrow and secrete IgE antibodies into the blood. (E) The secreted IgE antibodies 
reach the local respiratory mucosal tissues to bind to mast cells and maintain immediate 
hypersensitivity. 
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Figure 1. 
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Figure 2. 
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Figure 3. 
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